Exclusive

Publication

Byline

Location

US Patent Issued to Celgene on Sept. 15 for "Cereblon binding compounds, compositions thereof, and methods of treatment therewith" (California, Colorado Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,170, issued on Sept. 15, was assigned to Celgene Corp. (Summit, N.J.). "Cereblon binding compounds, compositions thereof, and methods of t... Read More


US Patent Issued to NEWAMSTERDAM PHARMA on Sept. 15 for "Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases" (British, Japanese, Dutch Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,171, issued on Sept. 15, was assigned to NEWAMSTERDAM PHARMA B.V. (Naarden, Netherlands). "Cholesteryl ester transfer protein (CETP) inhib... Read More


US Patent Issued to ACADEMIA SINICA on Sept. 15 for "Method and composition for treating pain" (Taiwanese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,172, issued on Sept. 15, was assigned to ACADEMIA SINICA (Taiwan). "Method and composition for treating pain" was invented by Chin-Cheng C... Read More


US Patent Issued to Northwestern University on Sept. 15 for "Use of nucleotide synthesis inhibitors for targeted therapy in MLL3/4 compass mutant cancer" (Illinois Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,173, issued on Sept. 15, was assigned to Northwestern University (Evanston, Ill.). "Use of nucleotide synthesis inhibitors for targeted th... Read More


US Patent Issued to EIP Pharma on Sept. 15 for "Treatment of a selective population of patients having dementia with Lewy bodies" (Massachusetts Inventor)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,174, issued on Sept. 15, was assigned to EIP Pharma LLC (Boston). "Treatment of a selective population of patients having dementia with Le... Read More


US Patent Issued to LIQMEDS WORLDWIDE on Sept. 15 for "Liquid oral formulations for PDE V inhibitors" (Indian Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,175, issued on Sept. 15, was assigned to LIQMEDS WORLDWIDE Ltd. (Weedon, Great Britain). "Liquid oral formulations for PDE V inhibitors" w... Read More


US Patent Issued to University of Maryland, Baltimore, The United States of America as represented by the Department of Veterans Affairs on Sept. 15 for "Non-catalytic substrate-selective p38Alpha-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof" (Maryland Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,176, issued on Sept. 15, was assigned to University of Maryland, Baltimore (Baltimore) and The United States of America as represented by t... Read More


US Patent Issued to GUANGZHOU JOYO PHARMATECH on Sept. 15 for "Macrocyclic derivative and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,177, issued on Sept. 15, was assigned to GUANGZHOU JOYO PHARMATECH Co. LTD. (Guangzhou, China). "Macrocyclic derivative and use thereof" w... Read More


US Patent Issued to NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING on Sept. 15 for "Preparation for ethinylestradiol-cyclodextrin complex and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,178, issued on Sept. 15, was assigned to NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING (Beijing). "Preparation for ethinylestradiol-cycl... Read More


US Patent Issued to AUGUSTA UNIVERSITY RESEARCH INSTITUTE, Vitrovita on Sept. 15 for "Progesterone formulation to trigger ovulation and provide luteal phase support" (Michigan, Texas Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,179, issued on Sept. 15, was assigned to AUGUSTA UNIVERSITY RESEARCH INSTITUTE INC. (Augusta, Ga.) and Vitrovita LLC (Houston). "Progester... Read More